Avoiding Common Mistakes in Regulatory Amendment Submissions
Protocol amendments are routine in clinical trials—but errors in submitting them to regulatory authorities and ethics committees can cause serious setbacks. Submissions that lack proper documentation, contain inconsistencies, or fail to meet country-specific requirements may lead to delays, rejection, or compliance findings.
Click to read the full article.